81 FR 6026 - The National Heart, Lung, and Blood Institute (NHLBI) Strategic Visioning: Draft Strategic Research Priorities; Request for Comments
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 23 (February 4, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 23 (February 4, 2016)
| Page Range | 6026-6027 | |
| FR Document | 2016-02120 |
[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)] [Notices] [Pages 6026-6027] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-02120] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The National Heart, Lung, and Blood Institute (NHLBI) Strategic Visioning: Draft Strategic Research Priorities; Request for Comments SUMMARY: The National Heart, Lung, and Blood Institute (NHLBI) is soliciting comments from the public on its Draft Strategic Research Priorities, which will help inform Institute-solicited research activities over the next decade. The draft document is available through the NHLBI Strategic Visioning Web site (https://www.nhlbi.nih.gov/about/documents/strategic-visioning/public-comment-period). DATES: To ensure consideration, written comments must be received by March 7, 2016. ADDRESSES: The Draft Strategic Research Priorities can be viewed here: (https://www.nhlbi.nih.gov/about/documents/strategic-visioning/public-comment-period). Please email comments to [email protected]. Email comments are preferred, but comments may also be submitted by regular mail to: NHLBI Office of the Director, Attn: Strategic Visioning Team, National Heart, Lung, and Blood Institute, Building 31, Room 5A48, 31 Center Drive MSC 2486, Bethesda, MD 20892. FOR FURTHER INFORMATION CONTACT: Dana Camak, Executive Assistant, Office of Science Policy, Engagement, Education, and Communications at the National Heart, Lung, and Blood Institute, NIH, 31 Center Dr., Building 31, Room 4A10, Bethesda, MD 20892-2480. Telephone: 301-496- 4236. Email: [email protected]. Additional information may be obtained at https://www.nhlbi.nih.gov/about/documents/strategic-visioning/public-comment-period. SUPPLEMENTARY INFORMATION: Background For more than 60 years, the NHLBI has supported research to reduce the burden of heart, lung, blood, and sleep disorders and diseases. For example, long-term research investments in cardiovascular basic, clinical and population sciences have contributed to a 78% decrease in death rates due to coronary heart disease, a greater understanding of the complexity of chronic lung disease, and to an increase in life expectancy for persons with sickle cell disease from 14 years to 40-60 years. However, heart, lung, and blood diseases remain leading causes of death for American men and women, and we face ongoing health challenges such as an aging population, rising health care costs, and continued gender and racial disparities. Over the last year, NHLBI has been engaged in a Strategic Visioning process that engages the NHLBI community to inform Institute-solicited research activities. The goals for the Strategic Visioning process span the NHLBI mission and include research on health and disease in heart, lung, blood, and sleep systems; the translation of research for prevention, diagnosis, and treatment of diseases; and the support of training and resources for biomedical researchers across the landscape. The strength of the NHLBI's Strategic Visioning process rests in the collective input of the diverse perspectives within the heart, lung, blood, and sleep community, including, but not limited to, scientists, academic institutions, patient communities, and the general public, allowing these stakeholders the opportunity to identify and catalyze areas where targeted investments are needed. In spring of 2015, the community identified scientific opportunities (Compelling Questions, or CQs) and barriers to research progress (Critical Challenges, or CCs) facing heart, lung, blood, and sleep research. NHLBI leadership, staff, and advisory groups reviewed the ideas to identify the highest priorities for the Institute based on timeliness, feasibility, and overall ability to advance the fields of study. Ultimately, more than 1,000 ideas were submitted to the Strategic Visioning Forum. Ideas came from all 50 states and from countries across the globe, representing diverse perspectives of scientists, academic institutions, patient communities, and the general public. Together the NHLBI, its Board of Extramural Experts, and the NHLBI Advisory Council, refined and synthesized the CQs and CCs as appropriate, and organized them under Objectives. The resulting CQs and CCs, as delineated in the Draft Strategic Research Priorities document, address important research avenues and support the Institute's strategic goals. The Draft Strategic Research Priorities document is not meant to encompass NHLBI's entire research portfolio, but instead is meant to reflect those areas of study that are currently deemed to be the most important, timely, and feasible for the Institute to address in its targeted/solicited research portfolio in the next decade. Request for Comments This notice invites public comment on NHLBI's Draft Strategic Research Priorities. We seek diverse perspectives including, but not limited to, that of patients, patient advocates, clinicians, and researchers, as well as federal agencies and for-profit and not-for- profit stakeholders. The comments will be important factors in finalizing the document and thereby shaping NHLBI's Institute-solicited future research directions. Privacy Act Notification Statement: Responses to this notice are voluntary. Respondents are advised that the [[Page 6027]] Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response. The NHLBI may use the information gathered to develop grant, contract, or other funding priorities and initiatives. This notice is for information and planning purposes only and should not be construed as a solicitation or as an obligation on the part of the Federal Government in general, the NIH, or the NHLBI specifically. The NHLBI does not intend to make any awards based on responses to this RFI or pay for the preparation of any information submitted or for the Government's use of such information. Dated: January 26, 2016. Gary H. Gibbons, Director, National Heart, Lung, and Blood Institute. [FR Doc. 2016-02120 Filed 2-3-16; 8:45 am] BILLING CODE 4140-01-P
![6026 Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices
DEPARTMENT OF HEALTH AND activities over the next decade. The treatment of diseases; and the support of
HUMAN SERVICES draft document is available through the training and resources for biomedical
NHLBI Strategic Visioning Web site researchers across the landscape.
National Institutes of Health (https://www.nhlbi.nih.gov/about/ The strength of the NHLBI’s Strategic
documents/strategic-visioning/public- Visioning process rests in the collective
National Institute of Allergy and comment-period). input of the diverse perspectives within
Infectious Diseases; Notice of Closed DATES: To ensure consideration, written the heart, lung, blood, and sleep
Meeting comments must be received by March 7, community, including, but not limited
Pursuant to section 10(d) of the 2016. to, scientists, academic institutions,
Federal Advisory Committee Act, as ADDRESSES: The Draft Strategic Research
patient communities, and the general
amended (5 U.S.C. App.), notice is Priorities can be viewed here: (https:// public, allowing these stakeholders the
hereby given of the following meeting. www.nhlbi.nih.gov/about/documents/ opportunity to identify and catalyze
The meeting will be closed to the strategic-visioning/public-comment- areas where targeted investments are
public in accordance with the period). Please email comments to needed. In spring of 2015, the
provisions set forth in sections community identified scientific
NHLBI_Vision@mail.nih.gov. Email
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., opportunities (Compelling Questions, or
comments are preferred, but comments
as amended. The grant applications and CQs) and barriers to research progress
may also be submitted by regular mail
(Critical Challenges, or CCs) facing
the discussions could disclose to: NHLBI Office of the Director, Attn:
heart, lung, blood, and sleep research.
confidential trade secrets or commercial Strategic Visioning Team, National
NHLBI leadership, staff, and advisory
property such as patentable material, Heart, Lung, and Blood Institute,
groups reviewed the ideas to identify
and personal information concerning Building 31, Room 5A48, 31 Center
the highest priorities for the Institute
individuals associated with the grant Drive MSC 2486, Bethesda, MD 20892.
based on timeliness, feasibility, and
applications, the disclosure of which FOR FURTHER INFORMATION CONTACT: overall ability to advance the fields of
would constitute a clearly unwarranted Dana Camak, Executive Assistant, Office study.
invasion of personal privacy. of Science Policy, Engagement, Ultimately, more than 1,000 ideas
Name of Committee: National Institute of Education, and Communications at the were submitted to the Strategic
Allergy and Infectious Diseases Special National Heart, Lung, and Blood Visioning Forum. Ideas came from all 50
Emphasis Panel; NIAID Peer Review Meeting. Institute, NIH, 31 Center Dr., Building states and from countries across the
Date: February 26, 2016. 31, Room 4A10, Bethesda, MD 20892– globe, representing diverse perspectives
Time: 1:00 p.m. to 3:00 p.m. 2480. Telephone: 301–496–4236. Email: of scientists, academic institutions,
Agenda: To review and evaluate grant NHLBI_Vision@mail.nih.gov. Additional
applications. patient communities, and the general
information may be obtained at public.
Place: National Institutes of Health, Room
3C100, 5601 Fishers Lane, Rockville, MD https://www.nhlbi.nih.gov/about/ Together the NHLBI, its Board of
20892 (Telephone Conference Call). documents/strategic-visioning/public- Extramural Experts, and the NHLBI
Contact Person: Brenda L. Fredericksen, comment-period. Advisory Council, refined and
Ph.D., Assistant Professor, Scientific Review SUPPLEMENTARY INFORMATION: synthesized the CQs and CCs as
Program, Division of Extramural Activities, appropriate, and organized them under
Room # 3G22A, National Institutes of Health/Background
Objectives. The resulting CQs and CCs,
NIAID, 5601 Fishers Lane, MSC 9823, For more than 60 years, the NHLBI as delineated in the Draft Strategic
Bethesda, MD 20892–9823, (240) 669–5052, has supported research to reduce the
brenda.fredericksen@nih.gov.
Research Priorities document, address
burden of heart, lung, blood, and sleep important research avenues and support
(Catalogue of Federal Domestic Assistance disorders and diseases. For example,
Program Nos. 93.855, Allergy, Immunology,
the Institute’s strategic goals. The Draft
long-term research investments in Strategic Research Priorities document
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
cardiovascular basic, clinical and is not meant to encompass NHLBI’s
population sciences have contributed to
Research, National Institutes of Health, HHS) entire research portfolio, but instead is
a 78% decrease in death rates due to meant to reflect those areas of study that
Dated: January 29, 2016. coronary heart disease, a greater are currently deemed to be the most
Natasha M. Copeland, understanding of the complexity of important, timely, and feasible for the
Program Analyst, Office of Federal Advisory chronic lung disease, and to an increase Institute to address in its targeted/
Committee Policy. in life expectancy for persons with solicited research portfolio in the next
[FR Doc. 2016–02051 Filed 2–3–16; 8:45 am] sickle cell disease from 14 years to 40– decade.
BILLING CODE 4140–01–P 60 years. However, heart, lung, and
blood diseases remain leading causes of Request for Comments
death for American men and women, This notice invites public comment
DEPARTMENT OF HEALTH AND and we face ongoing health challenges on NHLBI’s Draft Strategic Research
HUMAN SERVICES such as an aging population, rising Priorities. We seek diverse perspectives
health care costs, and continued gender including, but not limited to, that of
National Institutes of Health and racial disparities. patients, patient advocates, clinicians,
The National Heart, Lung, and Blood Over the last year, NHLBI has been and researchers, as well as federal
engaged in a Strategic Visioning process agencies and for-profit and not-for-profit
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Institute (NHLBI) Strategic Visioning:
Draft Strategic Research Priorities; that engages the NHLBI community to stakeholders. The comments will be
Request for Comments inform Institute-solicited research important factors in finalizing the
activities. The goals for the Strategic document and thereby shaping NHLBI’s
SUMMARY: The National Heart, Lung, and Visioning process span the NHLBI Institute-solicited future research
Blood Institute (NHLBI) is soliciting mission and include research on health directions.
comments from the public on its Draft and disease in heart, lung, blood, and Privacy Act Notification Statement:
Strategic Research Priorities, which will sleep systems; the translation of Responses to this notice are voluntary.
help inform Institute-solicited research research for prevention, diagnosis, and Respondents are advised that the
VerDate Sep<11>2014 17:21 Feb 03, 2016 Jkt 238001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1](https://thefederalregister.org/doc/81_FR_6049/page/1.svg)
![Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 6027
Government is under no obligation to Name of Committee: Center for Scientific Contact Person: Ping Wu, Ph.D., Scientific
acknowledge receipt of the information Review Special Emphasis Panel; Member Review Officer, HDM IRG, Center for
received or provide feedback to Conflict: Psychosocial Risks and Disease Scientific Review, National Institutes of
Prevention. Health, 6701 Rockledge Drive, Room 3166,
respondents with respect to any
Date: March 1, 2016. Bethesda, MD 20892, 301–451–8428, wup4@
information submitted. No proprietary, Time: 1:00 p.m. to 4:00 p.m.
classified, confidential, or sensitive csr.nih.gov.
Agenda: To review and evaluate grant
information should be included in your applications. (Catalogue of Federal Domestic Assistance
response. The NHLBI may use the Place: National Institutes of Health, 6701 Program Nos. 93.306, Comparative Medicine;
information gathered to develop grant, Rockledge Drive, Bethesda, MD 20892 93.333, Clinical Research, 93.306, 93.333,
contract, or other funding priorities and (Virtual Meeting). 93.337, 93.393–93.396, 93.837–93.844,
initiatives. Contact Person: Weijia Ni, Ph.D., Chief/ 93.846–93.878, 93.892, 93.893, National
This notice is for information and Scientific Review Officer, Center for Institutes of Health, HHS)
Scientific Review, National Institutes of
planning purposes only and should not Dated: January 29, 2016.
Health, 6701 Rockledge Drive, Room 3100,
be construed as a solicitation or as an MSC 7808, Bethesda, MD 20892, 301–594– Carolyn Baum,
obligation on the part of the Federal 3292, niw@csr.nih.gov.
Government in general, the NIH, or the Program Analyst, Office of Federal Advisory
Name of Committee: Center for Scientific Committee Policy.
NHLBI specifically. The NHLBI does not Review Special Emphasis Panel; PAR Panel:
intend to make any awards based on [FR Doc. 2016–02053 Filed 2–3–16; 8:45 am]
Environmental Contributors to Autism
responses to this RFI or pay for the Spectrum Disorders. BILLING CODE 4140–01–P
preparation of any information Date: March 2, 2016.
submitted or for the Government’s use Time: 8:00 a.m. to 4:00 p.m.
of such information. Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
applications. HUMAN SERVICES
Dated: January 26, 2016. Place: Cambria Hotels & Suites, 1 Helen
Gary H. Gibbons, Heneghan Way, Rockville, MD 20850. National Institutes of Health
Director, National Heart, Lung, and Blood Contact Person: Patricia Greenwel, Ph.D.,
Institute. Scientific Review Officer, Center for National Institute of Arthritis and
[FR Doc. 2016–02120 Filed 2–3–16; 8:45 am] Scientific Review, National Institutes of
Musculoskeletal and Skin Diseases;
Health, 6701 Rockledge Drive, Room 2178,
BILLING CODE 4140–01–P
MSC 7818, Bethesda, MD 20892, 301–435– Notice of Closed Meeting
1169, greenwep@csr.nih.gov.
Name of Committee: Center for Scientific
Pursuant to section 10(d) of the
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as
Review Special Emphasis Panel;
HUMAN SERVICES Fellowships: Sensory and Motor amended (5 U.S.C. App.), notice is
Neurosciences, Cognition and Perception. hereby given of the following meeting.
National Institutes of Health Date: March 3–4, 2016. The meeting will be closed to the
Time: 8:00 a.m. to 5:00 p.m.
Center for Scientific Review; Notice of Agenda: To review and evaluate grant
public in accordance with the
Closed Meetings applications. provisions set forth in sections
Place: Pier 2620 Hotel Fisherman’s Wharf, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Pursuant to section 10(d) of the
2620 Jones Street, San Francisco, CA 94133. as amended. The grant applications and
Federal Advisory Committee Act, as
Contact Person: Sharon S Low, Ph.D., the discussions could disclose
amended (5 U.S.C. App.), notice is Scientific Review Officer, Center for
hereby given of the following meetings. confidential trade secrets or commercial
Scientific Review, National Institutes of property such as patentable material,
The meetings will be closed to the Health, 6701 Rockledge Drive, Room 5104,
public in accordance with the and personal information concerning
MSC 7846, Bethesda, MD 20892, 301–237–
provisions set forth in sections 1487, lowss@csr.nih.gov.
individuals associated with the grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which
Name of Committee: Center for Scientific
as amended. The grant applications and Review Special Emphasis Panel; would constitute a clearly unwarranted
the discussions could disclose Fellowships: Biochemistry and Biophysical invasion of personal privacy.
confidential trade secrets or commercial Chemistry. Name of Committee: Arthritis and
property such as patentable material, Date: March 3–4, 2016. Musculoskeletal and Skin Diseases Initial
and personal information concerning Time: 8:00 a.m. to 4:00 p.m. Review Group Arthritis and Musculoskeletal
Agenda: To review and evaluate grant
individuals associated with the grant and Skin Diseases Special Grants Review
applications.
applications, the disclosure of which Place: National Institutes of Health, 6701 Committee.
would constitute a clearly unwarranted Rockledge Drive, Bethesda, MD 20892 Date: February 25–26, 2016.
invasion of personal privacy. (Virtual Meeting). Time: 7:00 a.m. to 5:00 p.m.
Name of Committee: Center for Scientific Contact Person: David R Jollie, Ph.D., Agenda: To review and evaluate grant
Review Special Emphasis Panel; Language Scientific Review Officer, Center for applications.
and Communication. Scientific Review, National Institutes of Place: Embassy Suites at the Chevy Chase
Date: February 22, 2016. Health, 6701 Rockledge Drive, Room 4166, Pavilion, 4300 Military Rd. NW, Washington,
Time: 1:00 p.m. to 2:00 p.m. MSC 7806, Bethesda, MD 20892, (301)–437– DC 20015.
Agenda: To review and evaluate grant 7927, jollieda@csr.nih.gov. Contact Person: Helen Lin, Ph.D.,
asabaliauskas on DSK5VPTVN1PROD with NOTICES
applications. Name of Committee: Center for Scientific Scientific Review Officer, NIH/NIAMS/RB,
Place: Argonaut Hotel, 495 Jefferson Street, Review Special Emphasis Panel; Member 6701 Democracy Blvd., Suite 800, Plaza One,
San Francisco, CA 94109. Conflict: Research Project Grant. Bethesda, MD 20817, 301–594–4952, linh1@
Contact Person: Weijia Ni, Ph.D., Chief/ Date: March 3, 2016. mail.nih.gov.
Scientific Review Officer, Center for Time: 10:00 a.m. to 5:00 p.m.
Scientific Review, National Institutes of Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance
Health, 6701 Rockledge Drive, Room 3100, applications. Program Nos. 93.846, Arthritis,
MSC 7808, Bethesda, MD 20892, (301) 594– Place: National Institutes of Health, 6701 Musculoskeletal and Skin Diseases Research,
3292, niw@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892. National Institutes of Health, HHS)
VerDate Sep<11>2014 17:21 Feb 03, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1](https://thefederalregister.org/doc/81_FR_6049/page/2.svg)
Document Created: 2016-02-04 00:30:48
Document Modified: 2016-02-04 00:30:48
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | To ensure consideration, written comments must be received by March 7, 2016. | |
| Contact | Dana Camak, Executive Assistant, Office of Science Policy, Engagement, Education, and Communications at the National Heart, Lung, and Blood Institute, NIH, 31 Center Dr., Building 31, Room 4A10, Bethesda, MD 20892-2480. Telephone: 301-496- 4236. Email: [email protected] Additional information may be obtained at https://www.nhlbi.nih.gov/about/documents/strategic- visioning/public-comment-period. | |
| FR Citation | 81 FR 6026 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR